Literature DB >> 30471680

Neurocognitive effects of cannabis: Lessons learned from human experimental studies.

Marco Colizzi1, Sagnik Bhattacharyya2.   

Abstract

The following chapter offers an overview of results of experimental studies conducted among healthy individuals examining the effects of acute administration of Δ9-THC and other cannabinoids, alone or in combination, on brain function and behavior, also as a function of previous cannabis exposure. In light of their methodological design, these studies have advanced the understanding of the neurobiological mechanisms increasing the risk of long-lasting cognitive dysfunction as well as psychosis in regular cannabis users. Also, direct and indirect evidence supports an alteration of different neurotransmitters, such as dopamine, glutamate, and gamma-aminobutyric acid, in modulating the manifestation of neurocognitive dysfunction and psychosis in the context of both acute and chronic cannabis exposure. Future multimodal neuroimaging studies will integrate the longitudinal information to track the long-term changes in brain neurochemistry and neurophysiology as well as other potential biomarkers induced by sustained cannabis use.
© 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabidiol; Cannabis; Cognition; Delta-9-tetrahydrocannabinol; Dopamine; Glutamate; Neurochemistry; Neurophysiology; Tolerance; fMRI

Mesh:

Substances:

Year:  2018        PMID: 30471680     DOI: 10.1016/bs.pbr.2018.08.010

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  6 in total

1.  Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats.

Authors:  Sarah Beggiato; Alessandro Ieraci; Maria Cristina Tomasini; Robert Schwarcz; Luca Ferraro
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-02-04       Impact factor: 5.067

2.  Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans.

Authors:  Marco Colizzi; Nathalie Weltens; Philip McGuire; Lukas Van Oudenhove; Sagnik Bhattacharyya
Journal:  Brain Sci       Date:  2019-04-25

Review 3.  Cannabidiol as a potential treatment for psychosis.

Authors:  Cathy Davies; Sagnik Bhattacharyya
Journal:  Ther Adv Psychopharmacol       Date:  2019-11-08

Review 4.  Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition.

Authors:  Marco Colizzi; Mirella Ruggeri; Sagnik Bhattacharyya
Journal:  Front Psychol       Date:  2020-05-14

5.  Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior.

Authors:  Marco Colizzi; Sagnik Bhattacharyya
Journal:  Brain Sci       Date:  2020-11-10

Review 6.  Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.

Authors:  Tonisha Kearney-Ramos; Margaret Haney
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-03-04       Impact factor: 5.201

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.